EarningsQ2 2024 Earnings Report

NovoCure (NVCRN) Q2 2024 Earnings Report

1 Followers

MX:NVCRN Q2 2024 EPS Results

Actual EPS-$5.70

Consensus EPS-$7.40

Beat/MissBeat by +$1.71

One Year Ago EPS-$9.92

Actual Revenue$2.76B

Expected Revenue$2.50B

Beat/MissBeat by +$266.94M

YoY Revenue Growth+19.28%

QuarterQ2 2024

Date07/25/2024

TimeBefore Open

Conference CallThursday, July 25, 2024

MX:NVCRN Upcoming Earnings

NovoCure's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:NVCRN Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-4.32 / -	-6.064	―
Jul 23, 2026	2026 (Q2)	-6.10 / -2.39	-6.615	63.89% (+4.23)
Apr 30, 2026	2026 (Q1)	-9.41 / -11.39	-5.696	-100.00% (-5.70)
Feb 26, 2026	2025 (Q4)	-7.55 / -4.04	-11.208	63.93% (+7.17)
Oct 30, 2025	2025 (Q3)	-7.72 / -6.06	-5.145	-17.86% (-0.92)
Jul 24, 2025	2025 (Q2)	-7.06 / -6.61	-5.696	-16.13% (-0.92)
Apr 24, 2025	2025 (Q1)	-8.53 / -5.70	-6.615	13.89% (+0.92)
Feb 27, 2025	2024 (Q4)	-6.32 / -11.21	-8.268	-35.56% (-2.94)
Oct 30, 2024	2024 (Q3)	-6.14 / -5.14	-8.452	39.13% (+3.31)
Jul 25, 2024	2024 (Q2)	-7.40 / -5.70	-9.922	42.59% (+4.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed